Latest Retail Investors News

NEXTDC has successfully closed the retail segment of its fully underwritten entitlement offer, securing A$480 million at A$12.70 per share. The total raise of approximately A$1.5 billion demonstrates strong investor backing ahead of the shares commencing trade on 19 May 2026.

Elevra Lithium has raised A$275 million through a fully underwritten institutional placement to fund its North American Lithium expansion and Moblan project development, supported by strong institutional demand.

Peel Mining has formally moved forward in its acquisition by Aeris Resources with the dispatch of the Scheme Booklet to shareholders, setting the stage for critical meetings on June 15.

BWP Group has launched the retail tranche of its fully underwritten $228 million entitlement offer at $3.77 per security, aiming to fund a $163 million development pipeline and reduce gearing.

NEXTDC has closed a A$1.7 billion subordinated hybrid securities offer fully backed by La Caisse, enhancing its liquidity to an estimated A$8.4 billion by June 30, 2026.

NEXTDC urges eligible retail shareholders to participate in its A$1.5 billion entitlement offer, priced at a 10.9% discount, with a top-up facility available. The retail offer closes on 11 May 2026, following recent senior debt commitments that bolster its growth plans.

Delorean Corporation has launched a $2.2 million Share Purchase Plan at $0.09 per share, matching a recent strategic placement to LMS Energy. The capital raise supports construction of key bioenergy projects in South Australia and New South Wales.

Terrain Minerals has completed major drilling campaigns across its flagship Lightning gold project and critical metals targets, setting the stage for a maiden resource estimate and advancing metallurgical studies on gallium and rare earth elements.

Tamboran Resources has closed its retail entitlement offer, adding A$24.8 million to a total equity raise of A$282.6 million to fund expanded drilling and development in the Beetaloo Basin.

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.

American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.

Santana Minerals advanced its Bendigo-Ophir Gold Project in New Zealand with a confirmed consent decision date, major equipment agreements, and a substantial capital raise, setting the stage for development.